Elevate-Derm West Conference—November 7 to 10, 2024; Scottsdale, Arizona

Whitney High, MD: Challenging Nonmelanoma Skin Cancer Management

Dr. Whitney High breaks down the biopsy and diagnosis process for rare nonmelanoma skin cancers like atypical fibroxanthoma and pleomorphic dermal sarcoma.

Topics Covered:

  • Nonmelanoma skin cancer management
  • Biopsy techniques for rare skin tumors
  • Diagnosing atypical fibroxanthoma and pleomorphic dermal sarcoma

Explore Related Resources:

Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids

 

Talimogene Laherparepvec in Non-Melanoma Cancers

MORE COVERAGE FROM ELEVATE DERM FALL 2024

Dr. Marghoob discusses how the microanatomy of the face, palms, and nails impacts diagnosing melanomas.

Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment. Listen to Dr. Song’s full recap on our JCAD Podcast

Dr. Jenny Murase reviews a decade of insights on safety considerations for dermatologic treatments for pregnant and lactating patients. Topics Covered: Safe dermatologic treatments during

Dr. Murase reviews a decade of insights on safety considerations for dermatologic treatments for pregnant and lactating patients.

Dr. Hsiao discusses alternate long-term therapeutic options for patients with CSU.

Dr. High discusses two immunostains, p16 and PRAME, as well as gene expression profiling, as helpful tools for identifying melanoma.

Dr. High shares tips and insights regarding specialized considerations for biopsying a wide range of skin lesions.

Dr. Jennifer Hsiao provides key takeaways from her presentation on hidradenitis suppurativa, focusing on unroofing procedures and treatment strategies. Topics Covered: Surgical unroofing techniques for

Dr. Chilukuri discusses managing hyperpigmentation with pulse wave radiofrequency, chemical peels, and lasers.

Dr. Chilukuri discusses treating both medical and aesthetic dermatological concerns, including acne, hyperpigmentation, and scars, with cosmetic treatments.

Dr. Hawkes discusses the dermatological treatment of patients with cancer, whose immune system activating cancer treatments lead to cutaneous immunotoxicities, such as pruritus, psoriasis, and

Dr. Hawkes discusses the closing gap between biologics and oral treatments for psoriasis and provides an update on a new oral IL-23 receptor inhibitor currently

Dr. Swanson discusses emerging treatments for atopic dermatitis, psoriasis, and alopecia areata in pediatric patients.